Bioactive TGF-β can associate with lipoproteins and is enriched in those containing apolipoprotein E3

Journal of Neurochemistry

Volumn 110, Issue 4, 2009, Pages 1254-1262

  Tesseur, Ina ^a,e   Zhang, Hui ^a   Brecht, Walter ^b   Corn, Jacob ^b   Gong, Jian Sheng ^c   Yanagisawa, Katsuhiko ^c   Michikawa, Makoto ^c   Weisgraber, Karl ^b   Huang, Yadong ^b   Wyss Coray, Tony ^a,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c National Center for Geriatrics and Gerontology   (Japan)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Alzheimer's disease; Apolipoprotein E; Lipoprotein; Neuroprotective; Transforming growth factor

Indexed keywords

APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; ISOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; VERY LOW DENSITY LIPOPROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; ATHEROSCLEROSIS; CONTROLLED STUDY; HUMAN; HYDROPHOBICITY; MOUSE; NEUROPROTECTION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RISK FACTOR; SIGNAL TRANSDUCTION;

ANIMALS; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ASTROCYTES; CELL LINE; CELLS, CULTURED; HEPATOCYTES; HUMANS; LIPID METABOLISM; LIPOPROTEINS; MICE; MICE, KNOCKOUT; PROTEIN ISOFORMS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 67651151527     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06222.x     Document Type: Article

References (37)

1. Alberts M. J., Graffagnino C., McClenny C., DeLong D., Strittmatter W., Saunders A. M. Roses A. D. (1995) ApoE genotype and survival from intracerebral haemorrhage. Lancet 346, 575.
2. Bonyadi M., Rusholme S. A. B., Cousins F. M., Su H. C., Biron C. A., Farrall M. Akhurst R. J. (1997) Mapping of a major genetic modifier of embryonic lethality in TGFβ1 knockout mice. Nat. Genet. 15, 207 211.
3. Brionne T. C., Tesseur I., Masliah E. Wyss-Coray T. (2003) Loss of TGF-beta1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40, 1133 1145.
4. Cabello-Verrugio C. Brandan E. (2007) A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1. J. Biol. Chem. 282, 18842 18850.
5. Chen C. L., Huang S. S. Huang J. S. (2008) Cholesterol modulates cellular TGF-beta responsiveness by altering TGF-beta binding to TGF-beta receptors. J. Cell. Physiol. 215, 223 233.
6. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L. Pericak-Vance M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921 923.
7. Derynck R. Zhang Y. E. (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577 584.
8. Dubois C. M., Blanchette F., Laprise M. H., Leduc R., Grondin F. Seidah N. G. (2001) Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. Am. J. Pathol. 158, 305 316.
9. Fagan A. M., Holtzman D. M., Munson G. et al. (1999) Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. J. Biol. Chem. 274, 30001 30007.
10. Gillespie L. N., Clark G. M., Bartlett P. F. Marzella P. L. (2001) LIF is more potent than BDNF in promoting neurite outgrowth of mammalian auditory neurons in vitro. Neuroreport 12, 275 279.
11. Grainger D. J., Byrne C. D., Witchell C. M. Metcalfe J. C. (1997) Transforming growth factor β is sequestered into an inactive pool by lipoproteins. J. Lipid Res. 38, 2344 2352.
12. Hart P. J., Deep S., Taylor A. B., Shu Z., Hinck C. S. Hinck A. P. (2002) Crystal structure of the human TβR2 ectodomain-TGF-β3 complex. Nat. Struct. Biol. 9, 203 208.
13. Hecker K. H. Roux K. H. (1996) High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR. BioTechniques 20, 478 485.
14. Hinck A. P., Archer S. J., Qian S. W. et al. (1996) Transforming growth factor β1: three-dimensional structure in solution and comparison with the x-ray structure of transforming browth factor β2. Biochemistry 35, 8517 8534.
15. Huang Y., Liu X. Q., Rall S. C. Jr., Taylor J. M., von Eckardstein A., Assmann G. Mahley R. W. (1998) Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J. Biol. Chem. 273, 26388 26393.
16. Kirsch T., Sebald W. Dreyer M. K. (2000) Crystal structure of the BMP-2-BRIA ectodomain complex. Nat. Struct. Biol. 7, 492 496.
17. Mahley R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622 630.
18. McCarron M. O., Muir K. W., Weir C. J., Dyker A. G., Bone I., Nicoll J. A. R. Lees K. R. (1998) The apolipoprotein E η4 allele and outcome in cerebrovascular disease. Stroke 29, 1882 1887.
19. Ordovas J. M. Osgood D. (1998) Preparative isolation of plasma lipoproteins using fast protein liquid chromatography (FPLC). Methods Mol. Biol. 110, 105 111.
20. Panakova D., Sprong H., Marois E., Thiele C. Eaton S. (2005) Lipoprotein particles are required for Hedgehog and Wingless signalling. Nature 435, 58 65.
21. Raber J., Bongers G., LeFevour A., Buttini M. Mucke L. (2002) Androgens protect against apolipoprotein E4-induced cognitive deficits. J. Neurosci. 22, 5204 5209.
22. Ren R. F. Flanders K. C. (1996) Transforming growth factors-β protect primary rat hippocampal neuronal cultures from degeneration induced by β-amyloid peptide. Brain Res. 732, 16 24.
23. Ren R. F., Hawver D. B., Kim R. S. Flanders K. C. (1997) Transforming growth factor-β protects human hNT cells from degeneration induced by β-amyloid peptide: involvement of the TGF-β type II receptor. Mol. Brain Res. 48, 315 322.
24. Saharinen J. Keski-Oja J. (2000) Specific sequence motif of 8-Cys repeats of TGF-β binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-β. Mol. Biol. Cell 11, 2691 2704.
25. Saunders A. M., Schmader K., Breitner J. C. S. et al. (1993) Apolipoprotein E η4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342, 710 711.
26. Schurgers L. J. Vermeer C. (2002) Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim. Biophys. Acta 1570, 27 32.
27. Segrest J. P., Jones M. K., De Loof H., Brouillette C. G., Venkatachalapathi Y. V. Anantharamaiah G. M. (1992) The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res. 33, 141 166.
28. Singh N. N. Ramji D. P. (2006) The role of transforming growth factor-beta in atherosclerosis. Cytokine Growth Factor Rev. 17, 487 499.
29. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Engchild J., Salvesen G. S. Roses A. D. (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl Acad. Sci. USA 90, 1977 1981.
30. Tesseur I., Zou K., Berber E., Zhang H. Wyss-Coray T. (2006) Highly sensitive and specific bioassay for measuring bioactive TGF-beta. BMC Cell Biol. 7, 15.
31. Traber M. G., Rallis M., Podda M., Weber C., Maibach H. I. Packer L. (1998) Penetration and distribution of alpha-tocopherol, alpha- or gamma-tocotrienols applied individually onto murine skin. Lipids 33, 87 91.
32. Tseng W. F., Huang S. S. Huang J. S. (2004) LRP-1/TbetaR-V mediates TGF-beta1-induced growth inhibition in CHO cells. FEBS Lett. 562, 71 78.
33. Ulich T. R., Yin S., Guo K., Yi E. S., Remick D. del Castillo J. (1991) Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am. J. Pathol. 138, 1097 1101.
34. Vaisar T., Pennathur S., Green P. S. et al. (2007) Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 117, 746 756.
35. Webb D. J., Wen J., Lysiak J. J., Umans L., Van Leuven F. Gonias S. L. (1996) Murine alpha-macroglobulins demonstrate divergent activities as neutralizers of transforming growth factor-beta and as inducers of nitric oxide synthesis. A possible mechanism for the endotoxin insensitivity of the alpha2-macroglobulin gene knock-out mouse. J. Biol. Chem. 271, 24982 24988.
36. Wyss-Coray T., Lin C., Yan F., Yu G., Rohde M., McConlogue L., Masliah E. Mucke L. (2001) TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612 618.
37. Zhu Y., Yang G.-Y., Ahlemeyer B., Pang L., Che X.-M., Culmsee C., Klumpp S. Krieglstein J. (2002) Transforming growth factor-β1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 22, 3898 3909.